Apolipoprotein C-III in patients with systemic lupus erythematosus

Abstract Background Systemic lupus erythematosus (SLE) has been associated with atherosclerotic cardiovascular disease (CV) and an altered lipid profile. High levels of apolipoprotein C-III (ApoC3) are associated with elevated triglyceride levels and an increased risk of CV. In the present study, we...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Candelaria Martín-González, Carmen Ferrer-Moure, Juan Carlos Quevedo-Abeledo, Antonia de Vera-González, Alejandra González-Delgado, Julio Sánchez-Martín, Miguel Á. González-Gay, Iván Ferraz-Amaro
Format: Artigo
Jezik:Inglês
Izdano: BMC 2022-05-01
Serija:Arthritis Research & Therapy
Teme:
Systemic lupus erythematosus
Apolipoprotein C3
Online dostop:https://doi.org/10.1186/s13075-022-02793-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki